RC
MGNX icon

Rangeley Capital’s MacroGenics MGNX Stock Holding History

Rangeley Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,500
Closed -$62.1K – 204
2026
Q1 		$62.1K Sell
21,500
-8,720
-29% -$18.6K 0.06% 128
2025
Q4 		$48.7K Hold
30,220
– – 0.04% 116
2025
Q3 		$50.8K Buy
30,220
+3,220
+12% +$5.21K 0.04% 119
2025
Q2 		$32.7K Buy
+27,000
New +$39.2K 0.04% 66

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Rangeley Capital's MGNX Position: Q2 2026 in Review

Rangeley Capital sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 21,500 shares — an estimated $62.1K sold.

Rangeley Capital first reported a position in MGNX in Q2 2025 and held it in 4 quarters. The position peaked at $62.1K in Q1 2026. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Rangeley Capital reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
  • Rangeley Capital sold 21,500 MacroGenics shares in Q2 2026, an estimated $62.1K.
  • Rangeley Capital first reported a position in MacroGenics in Q2 2025 and held it in 4 quarters.
  • Rangeley Capital's MacroGenics position peaked at $62.1K in Q1 2026.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.